Patient Decision Aid for Medication-Assisted Treatment for Opioid Use Disorder
Patient Decision Aid for Medication-Assisted Treatment for Opioid Use Disorder
批准号:
9765292
负责人:
YIH-ING HSER
金额:
$55.36万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2021-08-31
关键词:
AddressAdultAlcohol or Other Drugs useAttentionBuprenorphineCaliforniaCaringChronicClinicClinicalCluster randomized trialComplementContinuity of Patient CareCritical CareDecision AidDiagnosisDrug usageEffectivenessEvaluationFeedbackFocus GroupsFosteringFundingGrantImprisonmentImprove AccessInterviewKnowledgeLeadMedicalMental HealthModelingOpioidOutcomeOverdosePatient-Centered CarePatient-Focused OutcomesPatientsPharmaceutical PreparationsPharmacotherapyPhasePhysiciansProceduresProcessProviderPublic HealthQuestionnairesRandomized Controlled TrialsRecording of previous eventsRecordsResearchResearch PersonnelResourcesRiskRuralServicesSeveritiesSiteSystemTestingTime trendTrainingTreatment outcomeUnited StatesUnited States Substance Abuse and Mental Health Services AdministrationVermontWorkbasedata sharingdesignevidence basefield studyhealth care servicehealth care service utilizationimprovedimproved outcomeindexingintervention effectmedication compliancemedication-assisted treatmentmortalitymultilevel analysisopioid epidemicopioid use disorderoverdose deathpatient orientedphysical conditioningpreferenceprimary care settingresponseshared decision makingsupport toolstooltreatment adherencetreatment planning
中文摘要
为了解决阿片类药物危机,并与SAMHSA国家有针对性地应对阿片类药物的资金
危机赠款,加州的药物辅助治疗扩展项目将遵循佛蒙特州的枢纽
和辐射模式,建立加州中心辐射系统(CA H&SS),用于在
阿片类药物使用障碍(OUD)的药物辅助治疗(MAT),重点是初级治疗中的丁丙诺啡
护理机构。虽然佛蒙特州的中心和辐条阿片类药物治疗模式已经证明了有利的影响,
通过让患者参与慢性疾病的治疗计划,
条件,如。针对RFA-DA-18-005(扩大药物辅助治疗,
SAMHSA阿片类药物STR赠款背景下的阿片类药物使用障碍,R21/R33),该项目将开发
并测试一种名为药物辅助治疗患者决策辅助工具(PtDAMAT)的患者决策支持工具
用于CA H&SS。PtDA-MAT旨在(1)提高患者知识和参与度
并随后改善治疗依从性和结果,以及(2)支持临床医生告知和
与他们的OUD患者进行沿着连续护理的沟通。该项目将进行1年的R21
开发和试点测试PtDA-MAT,以促进CA H&SS的共同决策,随后3年
的R33,以评估PtDA-MAT在随机对照试验中的有效性。
R21研究的目标是:目标1。开发患者决策辅助工具(PtDA-MAT),
关于MAT的现有最佳科学证据以及来自患者和临床提供者的反馈,
临床优先级、感知效用和可接受性;目标2。进行PtDA-MAT的试点测试,
由专家小组指导并涉及关键利益攸关方(例如,病人,医生,
政策制定者)和实地测试。
R33研究的目的是通过进行阶梯楔试验来测试PtDA-MAT的有效性
CA H&SS(按农村与非农村地区分层)成人OUD的随机分组试验。患者
将通过(1)个人评估(基线、3个月和6个月)跟踪结局:药物使用,
用药过量、医疗保健利用和(2)临床和管理记录(平均24个月):
药物治疗状态和保留,身体和精神健康诊断,逮捕,监禁,控制
物质使用和死亡率。将应用多水平模型来检验干预效果,控制
可能的时间趋势。
我们提出的以患者为中心的决策工具考虑到了患者的价值观和偏好
并将纳入科学证据,以增加患者对可能的药物风险的了解,
利益、替代方案及其相关结果。PtDA-MAT可能有助于循证医学
决策和促进以患者为中心的护理,从而改善OUD患者的MAT结果。
英文摘要
To address the opioid crisis, and with funding from SAMHSA State Targeted Response to the Opioid
Crisis Grants, California’s Medication Assisted Treatment Expansion Project will follow after Vermont’s Hub
and Spoke model to establish a California Hub and Spoke system (CA H&SS) for capacity expansion in
medication-assisted treatment (MAT) for opioid use disorder (OUD), with a focus on buprenorphine in primary
care settings. While Vermont’s Hub and Spoke opioid treatment model has demonstrated favorable impacts,
patient outcomes can be improved by engaging patients collaboratively in treatment planning for chronic
conditions such as OUD. In response to RFA-DA-18-005 (Expanding Medication Assisted Treatment for
Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants, R21/R33), this project will develop
and test a patient decision support tool called Patient Decision Aid for Medication-Assisted Treatment (PtDAMAT)
for use in the CA H&SS. The PtDA-MAT is designed to (1) improve patient knowledge and involvement
and to subsequently improve treatment adherence and outcomes and (2) to support clinicians in informing and
communicating with their patients with OUD along a continuum of care. The project will conduct 1 year of R21
to develop and pilot-test the PtDA-MAT to facilitate shared decision making in CA H&SS, followed by 3 years
of R33 to assess the effectiveness of the PtDA-MAT in a randomized controlled trial.
The aims of the R21 study are: Aim 1. Develop a patient decision aid (PtDA-MAT) by incorporating
best available scientific evidence on MAT as well as feedback from patients and clinical providers related to
clinical priorities, perceived utility, and acceptability; Aim 2. Conduct pilot testing of the PtDA-MAT in an
iterative process guided by an expert panel and involving key stakeholders (e.g., patients, physicians,
policymakers) and field-testing.
The aim of the R33 study is to test the effectiveness of PtDA-MAT by conducting a stepped-wedge
cluster-randomized trial in CA H&SS (stratified by rural vs. non-rural areas) for adults with OUD. Patient
outcomes will be tracked by (1) personal assessments (baseline, 3 months, and 6 months): drug use,
overdose, healthcare utilization, and (2) clinical and administrative records (over an average of 24 months):
drug treatment status and retention, physical and mental health diagnoses, arrest, incarceration, controlled
substance use, and mortality. Multilevel models will be applied to test the intervention effects, controlling for
possible temporal trends.
The patient-centered decision tool we have proposed takes account of patient values and preferences
and will incorporate scientific evidence to increase patients’ understanding of possible medication risks,
benefits, alternatives, and their associated outcomes. The PtDA-MAT is likely to facilitate evidence-based
decisions and promote patient-centered care, leading to improved outcomes for MAT for patients with OUD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Greater Southern California Node of the Clinical Trials Network
-
批准号:10336684
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2019
-
负责人:YIH-ING HSER
-
依托单位:
Greater Southern California Node of the Clinical Trials Network
-
批准号:10173176
-
项目类别:
-
资助金额:$12.09万
-
财政年份:2019
-
负责人:YIH-ING HSER
-
依托单位:
Greater Southern California Node of the Clinical Trials Network
-
批准号:10359088
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:YIH-ING HSER
-
依托单位:
Greater Southern California Node of the Clinical Trials Network
-
批准号:10581587
-
项目类别:
-
资助金额:$66.25万
-
财政年份:2019
-
负责人:YIH-ING HSER
-
依托单位:
Real-Time Assessment of Triggers and Coping Responses in China
-
批准号:8507196
-
项目类别:
-
资助金额:$14.31万
-
财政年份:2012
-
负责人:YIH-ING HSER
-
依托单位:
Conference Series to Promote Global Health...
-
批准号:8598465
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:YIH-ING HSER
-
依托单位:
Conference Series to Promote Global Health...
-
批准号:8461796
-
项目类别:
-
资助金额:$4.75万
-
财政年份:2012
-
负责人:YIH-ING HSER
-
依托单位:
Conference Series to Promote Global Health...
-
批准号:8968237
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:YIH-ING HSER
-
依托单位:
Neurocognitive Mechanisms and Recovery from Addiction
-
批准号:8389493
-
项目类别:
-
资助金额:$22.15万
-
财政年份:2012
-
负责人:YIH-ING HSER
-
依托单位:
Real-Time Assessment of Triggers and Coping Responses in China
-
批准号:8382823
-
项目类别:
-
资助金额:$18.71万
-
财政年份:2012
-
负责人:YIH-ING HSER
-
依托单位:
A Long-term Follow-up Study of Drug-Dependent Mothers and Children
-
批准号:7465650
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2009
-
负责人:YIH-ING HSER
-
依托单位:
A Long-term Follow-up Study of Drug-Dependent Mothers and Children
-
批准号:7851243
-
项目类别:
-
资助金额:$41.19万
-
财政年份:2009
-
负责人:YIH-ING HSER
-
依托单位:
CALDAR Institute on Longitudinal Research Findings and Methods
-
批准号:7407348
-
项目类别:
-
资助金额:$2.49万
-
财政年份:2008
-
负责人:YIH-ING HSER
-
依托单位:
Drug Abuse: Epidemiology, Treatment Process, & Outcomes
-
批准号:8220945
-
项目类别:
-
资助金额:$11.37万
-
财政年份:2008
-
负责人:YIH-ING HSER
-
依托单位:
CALDAR Institute on Longitudinal Research Findings and Methods
-
批准号:9229004
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:YIH-ING HSER
-
依托单位:
CALDAR Institute on Longitudinal Research Findings and Methods
-
批准号:7561707
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:YIH-ING HSER
-
依托单位:
CALDAR Institute on Longitudinal Research Findings and Methods
-
批准号:7749045
-
项目类别:
-
资助金额:$2.49万
-
财政年份:2008
-
负责人:YIH-ING HSER
-
依托单位:
Improving Methadone Maintenance Treatment Compliance and Outcomes in China
-
批准号:7666102
-
项目类别:
-
资助金额:$14.63万
-
财政年份:2008
-
负责人:YIH-ING HSER
-
依托单位:
Drug Abuse: Epidemiology, Treatment Process, & Outcomes
-
批准号:8013334
-
项目类别:
-
资助金额:$11.37万
-
财政年份:2008
-
负责人:YIH-ING HSER
-
依托单位:
Reducing HIV/AIDS and Drug Abuse: Linking Compulsory Rehabilitation to Methadone
-
批准号:7544553
-
项目类别:
-
资助金额:$12.08万
-
财政年份:2008
-
负责人:YIH-ING HSER
-
依托单位:
海外基金